185 related articles for article (PubMed ID: 14582135)
21. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E; Polliack A
Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
[TBL] [Abstract][Full Text] [Related]
22. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
23. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital.
Gujral S; Polampalli SN; Badrinath Y; Kumar A; Subramanian PG; Nair R; Gupta S; Sengar M; Nair C
Leuk Lymphoma; 2009 Aug; 50(8):1290-300. PubMed ID: 19811331
[TBL] [Abstract][Full Text] [Related]
25. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
26. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
27. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
Sun Y; Wang SA; Sun T
Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
DiGiuseppe JA; Borowitz MJ
Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
[TBL] [Abstract][Full Text] [Related]
30. Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia.
Dorwal P; Mehra S; Pande A; Jain D; Smeeta G; Sachdev R; Raina V
Cytometry B Clin Cytom; 2015; 88(5):348-51. PubMed ID: 26013700
[TBL] [Abstract][Full Text] [Related]
31. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
32. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
33. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia.
Catovsky D
Hematol Oncol Clin North Am; 2004 Aug; 18(4):783-94, vii. PubMed ID: 15325698
[TBL] [Abstract][Full Text] [Related]
34. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses.
Serke S; Schwaner I; Yordanova M; Szczepek A; Huhn D
Cytometry; 2001 Apr; 46(2):98-104. PubMed ID: 11309819
[TBL] [Abstract][Full Text] [Related]
36. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
37. A cholesterol-dependent CD20 epitope detected by the FMC7 antibody.
Polyak MJ; Ayer LM; Szczepek AJ; Deans JP
Leukemia; 2003 Jul; 17(7):1384-9. PubMed ID: 12835728
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
Konoplev S; Medeiros LJ; Bueso-Ramos CE; Jorgensen JL; Lin P
Am J Clin Pathol; 2005 Sep; 124(3):414-20. PubMed ID: 16191510
[TBL] [Abstract][Full Text] [Related]
39. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
Rawstron AC; Kreuzer KA; Soosapilla A; Spacek M; Stehlikova O; Gambell P; McIver-Brown N; Villamor N; Psarra K; Arroz M; Milani R; de la Serna J; Cedena MT; Jaksic O; Nomdedeu J; Moreno C; Rigolin GM; Cuneo A; Johansen P; Johnsen HE; Rosenquist R; Niemann CU; Kern W; Westerman D; Trneny M; Mulligan S; Doubek M; Pospisilova S; Hillmen P; Oscier D; Hallek M; Ghia P; Montserrat E
Cytometry B Clin Cytom; 2018 Jan; 94(1):121-128. PubMed ID: 29024461
[TBL] [Abstract][Full Text] [Related]
40. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]